Company
United StatesPublic company, NASDAQ: NXGLNexgel, Inc (NASDAQ: NXGL), Langhorne, PA – FDA Inspections
Inspection records and compliance data for Nexgel, Inc in Langhorne, Pennsylvania. 1 FDA inspection on record, last inspected October 10, 2024. Publicly traded as NASDAQ: NXGL.
Company Profile
This profile covers Nexgel, Inc based in Langhorne, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected October 10, 2024.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 10, 2024 | Not classified | Medical Devices & Rad Health | 1253997 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Nexgel, Inc
Stock ticker
NXGL
Exchange
NASDAQ
Share price
$3.79
Market cap
$1.8M
Price as of
November 13, 2026
FEI Number
3016807311
Address
2150 Cabot Blvd W Ste B, Langhorne, Pennsylvania 19047, United States
Country
United States
ID: 8b4990ad-9a76-4aea-8031-f01c344481b4